This presentation will discuss primary factors to address in determining exposure and dosing regimens, as well as exposure durations, in planning developmental neurotoxicity investigations. Whether the investigator employs a single dose during pregnancy, or continuous dosing prior to and throughout pregnancy (as well as during early postnatal development), the following primary factors should be addressed: 1) Purpose of the study (e.g., descriptive [such as screening] or investigative [such as determining the mechanism of action]); 2) physicochemical properties of the test compound that affect its pharmacokinetics and pharmacodynamics; 3) ability of the test compound to induce or inhibit metabolic enzymes; 4) appropriateness and characteristics of the test species; 5) limiting factors, including the availability of test compound for evaluation (e.g ., small quantities of a newly synthesized drug); and, 6) a number of general, miscellaneous factors (e.g., complications of maternal or fetal toxicity from extended dosing durations). Selection of exposure and dosing regimen (s), and exposure durations, most appropriate for a particular developmental neurotoxicity assessment requires careful attention to these factors.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.